Raab & Moskowitz Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $271K | Sell |
748
-9
| -1% | -$3.08K | 0.05% | 176 |
|
|
2026
Q1 | $266K | Sell |
757
-91
| -11% | -$32.4K | 0.06% | 173 |
|
|
2025
Q4 | $278K | Hold |
848
| – | – | 0.06% | 171 |
|
|
2025
Q3 | $239K | Sell |
848
-16
| -2% | -$4.64K | 0.05% | 176 |
|
|
2025
Q2 | $241K | Buy |
864
+50
| +6% | +$14.2K | 0.06% | 174 |
|
|
2025
Q1 | $254K | Sell |
814
-1
| -0.1% | -$295 | 0.06% | 163 |
|
|
2024
Q4 | $212K | Sell |
815
-92
| -10% | -$27.3K | 0.05% | 167 |
|
|
2024
Q3 | $292K | Sell |
907
-17
| -2% | -$5.56K | 0.07% | 156 |
|
|
2024
Q2 | $289K | Buy |
924
+101
| +12% | +$29.7K | 0.08% | 148 |
|
|
2024
Q1 | $234K | Buy |
823
+50
| +6% | +$14.6K | 0.07% | 161 |
|
|
2023
Q4 | $223K | Sell |
773
-136
| -15% | -$37.1K | 0.07% | 158 |
|
|
2023
Q3 | $244K | Buy |
+909
| New | +$227K | 0.09% | 151 |
|
|
2023
Q2 | – | Sell |
-858
| Closed | -$207K | – | 165 |
|
|
2023
Q1 | $207K | Sell |
858
-25
| -3% | -$6.14K | 0.08% | 156 |
|
|
2022
Q4 | $232K | Buy |
+883
| New | +$237K | 0.09% | 146 |
|
|
2022
Q3 | – | Sell |
-908
| Closed | -$220K | – | 154 |
|
|
2022
Q2 | $220K | Buy |
908
+20
| +2% | +$4.9K | 0.09% | 150 |
|
|
2022
Q1 | $214K | Hold |
888
| – | – | 0.07% | 159 |
|
|
2021
Q4 | $200K | Buy |
+888
| New | +$187K | 0.07% | 167 |
|
|
2021
Q3 | – | Sell |
-933
| Closed | -$227K | – | 161 |
|
|
2021
Q2 | $227K | Hold |
933
| – | – | 0.08% | 148 |
|
|
2021
Q1 | $232K | Hold |
933
| – | – | 0.09% | 138 |
|
|
2020
Q4 | $214K | Buy |
933
+20
| +2% | +$4.61K | 0.09% | 143 |
|
|
2020
Q3 | $232K | Sell |
913
-80
| -8% | -$19.8K | 0.11% | 127 |
|
|
2020
Q2 | $234K | Buy |
993
+2
| +0.2% | +$456 | 0.11% | 123 |
|
|
2020
Q1 | $200K | Sell |
991
-7
| -0.7% | -$1.53K | 0.11% | 133 |
|
|
2019
Q4 | $240K | Buy |
+998
| New | +$220K | 0.09% | 143 |
|
|
2019
Q3 | – | Sell |
-1,126
| Closed | -$207K | – | 157 |
|
|
2019
Q2 | $207K | Buy |
+1,126
| New | +$202K | 0.09% | 151 |
|
|
2019
Q1 | – | Sell |
-1,281
| Closed | -$249K | – | 163 |
|
|
2018
Q4 | $249K | Buy |
1,281
+787
| +159% | +$154K | 0.12% | 140 |
|
|
2018
Q3 | $102K | Buy |
+494
| New | +$97.4K | 0.04% | 196 |
|
|
2016
Q4 | – | Sell |
-1,289
| Closed | -$215K | – | 137 |
|
|
2016
Q3 | $215K | Sell |
1,289
-182
| -12% | -$30.8K | 0.12% | 132 |
|
|
2016
Q2 | $223K | Hold |
1,471
| – | – | 0.13% | 125 |
|
|
2016
Q1 | $220K | Sell |
1,471
-30
| -2% | -$4.46K | 0.13% | 119 |
|
|
2015
Q4 | $243K | Sell |
1,501
-48
| -3% | -$7.54K | 0.14% | 114 |
|
|
2015
Q3 | $214K | Sell |
1,549
-181
| -10% | -$28.5K | 0.14% | 111 |
|
|
2015
Q2 | $265K | Sell |
1,730
-186
| -10% | -$29.8K | 0.16% | 107 |
|
|
2015
Q1 | $306K | Sell |
1,916
-175
| -8% | -$27.6K | 0.19% | 100 |
|
|
2014
Q4 | $333K | Sell |
2,091
-30
| -1% | -$4.67K | 0.19% | 98 |
|
|
2014
Q3 | $298K | Hold |
2,121
| – | – | 0.14% | 120 |
|
|
2014
Q2 | $251K | Hold |
2,121
| – | – | 0.12% | 133 |
|
|
2014
Q1 | $262K | Sell |
2,121
-300
| -12% | -$36.4K | 0.14% | 124 |
|
|
2013
Q4 | $276K | Buy |
+2,421
| New | +$275K | 0.16% | 122 |
|
Other funds holding AMGN
Raab & Moskowitz Asset Management's AMGN Position: Q2 2026 in Review
Raab & Moskowitz Asset Management reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $3.08K and leaving 748 shares worth $271K. The position accounts for 0.05% of the portfolio, ranked #176.
Raab & Moskowitz Asset Management first reported a position in AMGN in Q4 2013 and has held it in 39 quarters since. The position peaked at $333K in Q4 2014. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Raab & Moskowitz Asset Management held 748 shares of Amgen worth $271K as of Q2 2026.
- Raab & Moskowitz Asset Management sold 9 Amgen shares in Q2 2026, an estimated $3.08K.
- Amgen made up 0.05% of Raab & Moskowitz Asset Management's portfolio in Q2 2026, its #176 holding.
- Raab & Moskowitz Asset Management first reported a position in Amgen in Q4 2013 and has held it in 39 quarters since.
- Raab & Moskowitz Asset Management's Amgen position peaked at $333K in Q4 2014.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.